TY - JOUR
T1 - Effects of tumor necrosis factor-α and nitric oxide on prostaglandins secretion by the bovine oviduct differ in the isthmus and ampulla and depend on the phase of the estrous cycle
AU - Siemieniuch, Marta J.
AU - Woclawek-Potocka, Izabela
AU - Deptula, Katarzyna
AU - Okuda, Kiyoshi
AU - Skarzynski, Dariusz J.
N1 - Funding Information:
This research was supported by the Polish Academy of Sciences and a joint Polish-Japanese project under the PAS and JSPS agreement. MJS is a guest researcher from the Polish Academy of Sciences supported by the Post-Doctoral Fellowship Program of the Japan Society for the Promotion of Science (No. P 08733). MJS and IW-P were supported by Domestic Grants for Young Scientists of the Foundation for Polish Science (FNP, Program START, 2008 and 2006, respectively).
Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/9
Y1 - 2009/9
N2 - To determine the possible roles of tumor necrosis factor-α (TNFα) and nitric oxide (NO) in the bovine oviduct, ampulla and isthmus collected during the estrous cycle were exposed for 18 h to TNFα, NO donor (NONOate), NO synthase inhibitors (L-NOARG, L-NAME and AMT) and oxytocin (OT) as a positive control. Prostaglandins (PGs) and NO2/NO3 in conditioned media were measured. TNFα stimulated PGF2α secretion on Day 0 (onset of estrus = Day 0) and Days 2-3, in both the ampulla and isthmus, but on Days 18-20 only in ampulla. TNFα increased PGE 2 secretion in both fragments in each phase. NONOate did not affect PGF2α secretion on Days 18-20, whereas this NO donor stimulated PGF2α secretion in both fragments on Day 0 and Days 2-3. TNFα increased NO2/NO3 production in every examined phase in the ampulla and on Days 2-3 in the isthmus. L-NAME lowered NO 2/NO3 production regardless of phase or fragment. L-NOARG and AMT lowered NO2/NO3 production in both fragments on Day 0 and Days 2-3. The possible role of TNFα, NO or PGs on the oviductal contractility during the early-luteal phase was also examined. Neither TNFα nor NONOate influenced contractility in either fragment. Although PGF2α stimulated the contraction in both fragments, PGE 2 decreased it. When taken together, TNFα seems to play some role as a modulator of PGF2α and PGE2 production and for transferring the embryo from the oviduct to the uterus by stimulating NO production in the bovine oviduct.
AB - To determine the possible roles of tumor necrosis factor-α (TNFα) and nitric oxide (NO) in the bovine oviduct, ampulla and isthmus collected during the estrous cycle were exposed for 18 h to TNFα, NO donor (NONOate), NO synthase inhibitors (L-NOARG, L-NAME and AMT) and oxytocin (OT) as a positive control. Prostaglandins (PGs) and NO2/NO3 in conditioned media were measured. TNFα stimulated PGF2α secretion on Day 0 (onset of estrus = Day 0) and Days 2-3, in both the ampulla and isthmus, but on Days 18-20 only in ampulla. TNFα increased PGE 2 secretion in both fragments in each phase. NONOate did not affect PGF2α secretion on Days 18-20, whereas this NO donor stimulated PGF2α secretion in both fragments on Day 0 and Days 2-3. TNFα increased NO2/NO3 production in every examined phase in the ampulla and on Days 2-3 in the isthmus. L-NAME lowered NO 2/NO3 production regardless of phase or fragment. L-NOARG and AMT lowered NO2/NO3 production in both fragments on Day 0 and Days 2-3. The possible role of TNFα, NO or PGs on the oviductal contractility during the early-luteal phase was also examined. Neither TNFα nor NONOate influenced contractility in either fragment. Although PGF2α stimulated the contraction in both fragments, PGE 2 decreased it. When taken together, TNFα seems to play some role as a modulator of PGF2α and PGE2 production and for transferring the embryo from the oviduct to the uterus by stimulating NO production in the bovine oviduct.
KW - Cattle
KW - Nitric oxide
KW - Oviduct
KW - Prostaglandins
KW - TNFα
UR - http://www.scopus.com/inward/record.url?scp=70349113552&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349113552&partnerID=8YFLogxK
U2 - 10.3181/0901-RM-23
DO - 10.3181/0901-RM-23
M3 - Article
C2 - 19596830
AN - SCOPUS:70349113552
SN - 1535-3702
VL - 234
SP - 1056
EP - 1066
JO - Experimental Biology and Medicine
JF - Experimental Biology and Medicine
IS - 9
ER -